1. Home
  2. ELTX vs UONEK Comparison

ELTX vs UONEK Comparison

Compare ELTX & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • UONEK
  • Stock Information
  • Founded
  • ELTX 2011
  • UONEK 1980
  • Country
  • ELTX United States
  • UONEK United States
  • Employees
  • ELTX N/A
  • UONEK N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • UONEK Broadcasting
  • Sector
  • ELTX Health Care
  • UONEK Consumer Discretionary
  • Exchange
  • ELTX Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • ELTX 121.7M
  • UONEK 31.6M
  • IPO Year
  • ELTX N/A
  • UONEK N/A
  • Fundamental
  • Price
  • ELTX $8.50
  • UONEK $0.61
  • Analyst Decision
  • ELTX Strong Buy
  • UONEK
  • Analyst Count
  • ELTX 2
  • UONEK 0
  • Target Price
  • ELTX $9.50
  • UONEK N/A
  • AVG Volume (30 Days)
  • ELTX 50.6K
  • UONEK 162.4K
  • Earning Date
  • ELTX 08-12-2025
  • UONEK 08-07-2025
  • Dividend Yield
  • ELTX N/A
  • UONEK N/A
  • EPS Growth
  • ELTX N/A
  • UONEK N/A
  • EPS
  • ELTX N/A
  • UONEK N/A
  • Revenue
  • ELTX N/A
  • UONEK $437,499,000.00
  • Revenue This Year
  • ELTX N/A
  • UONEK N/A
  • Revenue Next Year
  • ELTX N/A
  • UONEK N/A
  • P/E Ratio
  • ELTX N/A
  • UONEK N/A
  • Revenue Growth
  • ELTX N/A
  • UONEK N/A
  • 52 Week Low
  • ELTX $3.35
  • UONEK $0.44
  • 52 Week High
  • ELTX $9.99
  • UONEK $1.57
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 63.32
  • UONEK 46.11
  • Support Level
  • ELTX $7.76
  • UONEK $0.56
  • Resistance Level
  • ELTX $8.94
  • UONEK $1.40
  • Average True Range (ATR)
  • ELTX 0.37
  • UONEK 0.12
  • MACD
  • ELTX -0.02
  • UONEK -0.01
  • Stochastic Oscillator
  • ELTX 54.38
  • UONEK 6.08

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: